Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology

ORCID: 0000-0002-1531-4294

Publication year:
All
31 - 37 out of 37Page size: 10
Sort by: 1st author
  1. Published

    Clinical Features and Natural Course of Diabetic Nephropathy

    Rossing, Peter & Frimodt-møller, M., 2018, Diabetic Nephropathy: Pathophysiology and Clinical Aspects. Roelofs, J. J. & Vogt, L. (eds.). Springer, p. 21-32

    Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

  2. Published

    Urinary tubular biomarkers as predictors of kidney function decline, cardiovascular events and mortality in microalbuminuric type 2 diabetic patients

    Rotbain Curovic, V., Hansen, T. W., Eickhoff, M. K., von Scholten, B. J., Reinhard, H., Jacobsen, P. K., Persson, F., Parving, H. & Rossing, Peter, 2018, In: Acta Diabetologica. 55, 11, p. 1143-1150 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Stratification of type 2 diabetes based on routine clinical markers

    Safai, N., Ali, A., Rossing, Peter & Ridderstråle, M., 2018, In: Diabetes Research and Clinical Practice. 141, p. 275-283

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Arterial-ventricular coupling in type 1 diabetes: arterial stiffness is associated with impaired global longitudinal strain in type 1 diabetes patients-the Thousand & 1 Study

    Theilade, S., Rossing, Peter, Jensen, J. S. & Jensen, M. T., 2018, In: Acta Diabetologica. 55, 1, p. 21-29

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes

    Tofte, N., Lindhardt, M., Adamova, K., Beige, J., Beulens, J. W. J., Birkenfeld, A. L., Currie, G., Delles, C., Dimos, I., Francová, L., Frimodt-Møller, M., Girman, P., Göke, R., Havrdova, T., Kooy, A., Mischak, H., Navis, G., Nijpels, G., Noutsou, M., Ortiz, A. & 10 others, Parvanova, A., Persson, F., Ruggenenti, P. L., Rutters, F., Rychlík, I., Spasovski, G., Speeckaert, M., Trillini, M., von der Leyen, H. & Rossing, Peter, 2018, In: Diabetic Medicine. 35, 10, p. 1375-1382 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    A genome-wide association study of diabetic kidney disease in subjects with type 2 diabetes

    Van Zuydam, N. R., Ahlqvist, E., Sandholm, N., Deshmukh, H., William Rayner, N., Abdalla, M., Ladenvall, C., Ziemek, D., Fauman, E., Robertson, N. R., McKeigue, P. M., Valo, E., Forsblom, C., Harjutsalo, V., Perna, A., Rurali, E., Loredana Marcovecchio, M., Igo, R. P., Lajer, M., Ahluwalia, T. S. & 7 others, Linneberg, Allan René, Witte, D. R., Grarup, Niels, Pedersen, Oluf Borbye, Hansen, Torben, Rossing, Peter & SUrrogate markers for Micro- and Macrovascular hard endpoints for Innovative diabetes Tools (SUMMIT) Consortium, S. M. F. M. A. M. H. E. F. I. D. T. (. C., 2018, In: Diabetes. 67, 7, p. 1414-1427 14 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trial

    de Zeeuw, D., Renfurm, R. W., Bakris, G., Rossing, Peter, Perkovic, V., Hou, F. F., Nangaku, M., Sharma, K., Heerspink, H. J. L., Garcia-Hernandez, A. & Larsson, T. E., 2018, In: The Lancet Diabetes and Endocrinology. 6, 12, p. 925-933 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 Next

ID: 12937790